Triple Your Impact This Holiday Season
Triple Your Impact This Holiday Season
Celebrate the holidays with a year-end gift that can go 3x as far to help provide care and support to the millions affected by Alzheimer's disease, and to advance critical research. But please hurry — this 3x Match Challenge ends soon.
Donate NowNARFE Members Help Power New Strides in Alzheimer's Treatment and Research
"History has shown us that approvals of the first drug in a new category will invigorate the field, increase investments
in new treatments, and generate greater innovation," says Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer and medical affairs lead. "We need to continue to diversify the pipeline to address this devastating disease through multiple pathways and in all communities, as we do other major diseases." NARFE has partnered with the Alzheimer's Association for nearly four decades to do just that. Since 1985, NARFE has raised more than $14 million for the Association's mission and has sponsored 85 research studies through the Association's rigorous grant-awarding program. Researchers and projects recently sponsored by NARFE include:- Jole Fiorito, Ph.D. (Columbia University Medical Center) — Can a novel compound help preserve nerve cell function and prevent memory loss in Alzheimer's disease?
- Silvia Fossati, Ph.D. (Temple University) — Can improving blood flow in the brain help to clear protein deposits and improve cognitive impairments in Alzheimer's?
- Yi-Chen Hsieh, Ph.D. (Brigham and Women's Hospital) — How may the clearance of nerve cell waste be associated with brain changes observed in Alzheimer's?
- JiaBei Lin, Ph.D. (University of Pennsylvania) — Can a protein found in yeast be used to moderate the harmful effects of beta-amyloid and tau in Alzheimer's?
- Megan Zuelsdorff, Ph.D. (University of Wisconsin-Madison) — How might a disadvantaged social environment increase risk for Alzheimer's?
"We are grateful for and inspired by NARFE members' longstanding and generous support of brilliant dementia scientists worldwide," Dr. Carrillo says. "Together, we will achieve our vision of a world without Alzheimer's and all other dementia."